General screen for carrier status and assessment of CF risk. This test will identify approximately 90% of Cystic Fibrosis (CF) mutations in the Caucasian population, and 97% in the Ashkenazi-Jewish population.
Methodology: PCR and Oligonucleotide Ligation Assay
Specimen Requirements: 2 lavender-top (EDTA) tubes (minimum: 3.0 mL of EDTA whole blood). Store specimen at room temperature after collection. Specimen must be sent immediately to the lab.
Complete “Cystic Fibrosis Screen” history sheet available from Meadville Medical Center Laboratory and send with patient or specimen. This from also may be found in “Forms-History/Patient Information” section of this manual. Include patient history, clinical information, reason for referral, and referring physician’s name and phone number.
2 mL of saliva in Oragene DNA Self-Collection kit is acceptable.
For genetic testing, original tube is required.
Yellow-top (ACD-A or ACD-B) are also acceptable.
Analytical Time: 8 days
Days Set Up: Monday through Sunday
83891 – Molec dx, isol or Extract of nucl acd
83900 – Molec dx, amp, tgt, multi 1st 2 seq.
83901 – x 13 Molec dx, amp, tgt multi addl seq
83909 – Molec dx, sep and ID by hi res
83912 – Molec dx; interp and report
83914 – x 23 Mutation ID-enzym lig. or prim ext, each